Jazz agrees $7.2bn deal to buy cannabis meds pathfinder GW PharmaJazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed Share XJazz agrees $7.2bn deal to buy cannabis meds pathfinder GW Pharmahttps://pharmaphorum.com/news/jazz-agrees-7-2bn-deal-to-buy-cannabis-meds-pathfinder-gw-pharma/
